Materials Review Through the Capitalist's Eyes — Trust as an Intangible Asset

To a capitalist, materials review does not read as a cost center. What the review protects is the largest asset that never appears on the balance sheet — trust. Its impairment feeds back into the cost of capital along the path traced in Vol. 9. This piece closes the series with the capitalist's yardstick and carries the argument back to the review floor.

01The Asset That Never Appears on the Balance Sheet

No one can explain the market capitalization of a pharmaceutical company as the sum of its plants, inventory, and cash. Most of the gap between book value and market value is filled by what the ledger does not carry — trust, brand, the relationship with the regulator, the reassurance a product name carries. The capitalist buys the stock knowing about that gap.

So for a capitalist, trust is not a matter of sentiment but a matter of the asset account. An intangible asset takes years to build and a single deviation to break. Inventory that burns is covered by insurance; trust that burns is reimbursed by no one. Recovery, again, takes years. Materials review is the activity that protects this hard-to-recover asset through everyday send-backs.

02Seeing Review as "Investment" in Intangibles — Supplementary Principle 3-1③ of the CG Code

It is not only about protection. Supplementary Principle 3-1③ of the Corporate Governance Code asks companies to disclose investment in human capital, intellectual property, and the like in a clear and concrete way, conscious of consistency with management strategy and the issues facing the business. Intangible assets are placed on the disclosure table as an "object of investment."

That single line changes how review is positioned. Seen as an expense, review is a candidate for cutting; seen as investment in an intangible asset, cutting it draws down future value. The same work reverses its meaning the moment the account it sits under is changed. The Ito Review, too, took up the relationship between intangible assets and corporate value as a point in raising that value. If the review budget can be explained as "investment in an intangible asset" rather than "expense," its treatment within management shifts.

03Deviations Do Happen — What the Surveillance Report Shows

Impairment of trust is not hypothetical. The Ministry of Health, Labour and Welfare's report on the surveillance of promotional information activities publishes, by type and with company names withheld, deviation cases in the provision of information on prescription drugs. Stressing efficacy while the evidence presented is thin; falling short in providing safety information — such deviations are, in fact, reported every year.

A single deviation chips away at trust and rides onto corporate value along the path traced in Vol. 9 — a rise in the risk premium feeding the cost of capital. The penalty figure that makes the news is a one-time outlay; the elevated cost of capital is an invoice that renews every year. The capitalist is watching the latter.

04Review Cuts Off the Path in Advance

So when is the asset protected? Once a deviation has reached the report, it is already too late — that is the capitalist's sense of time. Materials review sends back inappropriate information before it reaches the world. As seen in Vol. 9, as part of the internal controls required by Article 362, paragraph 4, item 6 of the Companies Act, review closes off the path of a deviation at its source.

This "in advance" quality is also what makes the value of review hard to see. A prevented deviation leaves no number. In a year when no accident occurred, the review's contribution is hard to credit. But for the capitalist, the rise in the cost of capital that did not happen is precisely the review's result. Just as a fire brigade that started no fire looks unremarkable, an unseen contribution needs words that translate it.

05Speaking About Review in the Capitalist's Language — and Back to the Floor

So what the reviewer should say to management is not "we send it back because the rules forbid it." It is: "this is the preservation of trust, an intangible asset, and an investment that prevents a rise in the cost of capital" — the language of the capitalist's yardstick. When value is shown in the other side's account, review is understood not as a cost center but as the front line that protects corporate value.

The board sees the same review as visible evidence that governance is working; management uses it not as a brake that stops the business but as a wheel that holds its direction. The view changes with where you stand, but the object protected is one — the trust that the ledger does not carry. Seen even from the capitalist's layer, the conclusion lands in the same place.

Each instance of review is no more than an accumulation of unglamorous send-backs. Yet that one instance forestalls a deviation that would ride onto the cost of capital through the risk premium. Read management's decisions at the capitalist's resolution, and return your own judgment in the other side's language — that is the craft for conveying to management, as investment in an intangible asset, a review function too easily seen as a cost center. The value of materials review lies, beyond compliance with the rules, in the preservation of corporate value.